Table 2.
Correlation of basic characteristics and response of the NSCLC patients to the overall survival
| Items | Median survival (months) (95% CI) | Univariate analysis P* |
|---|---|---|
| Age (years) | 0.859 | |
| <60 | 12.9 (8.1–17.7) | |
| ≥60 | 13.4 (9.4–17.5) | |
| Gender | 0.225 | |
| Male | 11.2 (6.8–15.7) | |
| Female | 15.0 (12.2–17.9) | |
| Smoking history | 0.004 | |
| Never-smoker | 15.0 (11.2–18.8) | |
| Smoker | 10.6 (6.8–14.5) | |
| Histology | 0.215 | |
| Adenocarcinoma | 14.6 (12.2–17.0) | |
| Nonadenocarcinoma | 8.0 (5.0–11.0) | |
| Previous chemotherapy | 0.760 | |
| 1–2 regimen | 12.9 (9.41–16.40) | |
| ≥3 regimens | 14.2 (10.7–17.7) | |
| ECOG PS | 0.140 | |
| 0–1 | 13.7 (10.2–17.2) | |
| 2 | 12.2 (1.4–23.0) |
Note:
*
Log-rank test.
Abbreviations: NSCLC, non-small-cell lung caner; ECOG, Eastern Cooperative Oncology Group; PS, performance status; CI, Confidence interval.